Kevin Nadolny is an associate at Grant & Eisenhofer, focusing on securities litigation, antitrust matters, and consumer litigation.
Mr. Nadolny’s casework includes representing shareholders in such actions as: In re Pfizer Inc. Securities Litigation ($486 million settlement); In re News Corporation Shareholder Derivative Litigation ($139 million settlement); In re Kinder Morgan Energy Partners, L.P. Derivative Litigation ($27.5 million settlement). He has also represented plaintiffs in antitrust matters such as: In re Aggrenox Antitrust Litigation; and Alaska Electrical Pension Fund v. Bank of America (concerning ISDA-fix price-fixing). Mr. Nadolny’s consumer litigation experience includes working as a member of the team prosecuting consumer protection claims against General Motors in relation to its allegedly faulty ignition switches.
He currently represents plaintiffs in In re Blue Cross Blue Shield Antitrust Litigation and In re Generic Pharmaceuticals Pricing Antitrust Litigation.
Mr. Nadolny is a 1998 graduate of the University of Minnesota. He received his J.D. and LL.M. (Transnational Law) from Temple University, Beasley School of Law.